ICAM1 and Alzheimer disease: In contrast, topical application of prednisolone and EFE (1 and 3 mg) markedly reduced the expression of TSLP, CD4+ T cells, IL-4, and ICAM-1 in skin lesions compared to that in the AD group (p < 0.01).